APOE THERPAR Share Price
Stocks
APGE
US03770N1019
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 135.07 USD | -0.01% |
|
0.00% | +78.95% |
| 03/09 | AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics | MT |
| 03/09 | Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry Index | CI |
| Market Cap | 1.02TCr 882.75Cr 834.34Cr 757.46Cr 1.42TCr 98TCr 1.43TCr 9.96TCr 3.85TCr 50TCr 3.83TCr 3.74TCr 1,58000Cr | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 929.23Cr 805.27Cr 761.11Cr 690.97Cr 1.3TCr 89TCr 1.3TCr 9.09TCr 3.51TCr 45TCr 3.49TCr 3.41TCr 1,44100Cr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
97.31% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APGE | Delayed | |
CBOE
| APGE | Real-time |
Last Transcript: APOE THERPAR
| 1 day | -0.01% | ||
| Current month | -0.01% | ||
| 1 month | +0.39% | ||
| 3 months | +58.46% | ||
| 6 months | +90.00% | ||
| Current year | +78.95% |
| 1 month | 134.54 |  | 135.09 |
| Current year | 60.35 | | 135.09 |
| 1 year | 35.39 | | 135.09 |
| 3 years | 14.19 | | 135.09 |
| 5 years | 14.19 | | 135.09 |
| 10 years | 14.19 | | 135.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
Carl Dambkowski
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Fairmount Funds Management LLC
| Issuer sale | Company | -3,40,855 | 0.5480% | |
| 03/09/26 | Issuer sale | Director | -48,780 | 0.0784% | ||
| 03/09/26 | Venrock Associates
| Issuer sale | Company | -21,15,853 | 3.4016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | 0.00% | +266.64% | +556.64% | 1.02TCr | |
| +0.22% | +0.07% | -1.90% | +8.24% | 4.58TCr | |
| -0.32% | +4.61% | +43.90% | +26.98% | 4.44TCr | |
| -4.36% | -5.66% | +338.30% | +516.88% | 4.39TCr | |
| +0.46% | -0.83% | +6.38% | +73.76% | 3.94TCr | |
| -0.17% | -3.22% | +10.29% | +38.69% | 3.13TCr | |
| -0.65% | +5.14% | +25.61% | +120.17% | 1.73TCr | |
| +3.30% | -5.03% | - | - | 1.57TCr | |
| +1.66% | +5.30% | +19.25% | +34.93% | 1.47TCr | |
| +0.86% | +9.05% | +0.47% | -33.54% | 1.33TCr | |
| Average | +0.10% | +0.35% | +78.77% | +149.19% | 2.76TCr | |
| Weighted average by Cap. | -0.38% | -0.26% | +79.67% | +139.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -37Cr -32Cr -30Cr -28Cr -52Cr -3.57TCr -52Cr -363.83Cr -140.59Cr -1.81TCr -139.77Cr -136.67Cr -5.77TCr | -50Cr -43Cr -41Cr -37Cr -69Cr -4.77TCr -70Cr -485.88Cr -187.75Cr -2.42TCr -186.66Cr -182.52Cr -7.71TCr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
